Genetic Signatures Limited (GSS.AX)

AUD 0.63

(-8.03%)

Operating Income Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual operating income in 2024 was -22.33 Million AUD , down -18.22% from previous year.
Genetic Signatures Limited's latest quarterly operating income in 2024 FY was -22.21 Million AUD , down -17.61% from previous quarter.
Genetic Signatures Limited reported an annual operating income of -18.89 Million AUD in 2023, down -736.7% from previous year.
Genetic Signatures Limited reported an annual operating income of 2.96 Million AUD in 2022, up 90.56% from previous year.
Genetic Signatures Limited reported a quarterly operating income of -12.09 Million AUD for 2024 Q2, down 0.0% from previous quarter.
Genetic Signatures Limited reported a quarterly operating income of -10.23 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Operating Income of Genetic Signatures Limited (2024 - 2013)

Year	Operating Income	Operating Income Growth
2024	-22.33 Million AUD	-18.22%
2023	-18.89 Million AUD	-736.7%
2022	2.96 Million AUD	90.56%
2021	1.55 Million AUD	132.24%
2020	-4.83 Million AUD	-34.2%
2019	-3.59 Million AUD	-5.91%
2018	-3.39 Million AUD	-22.1%
2017	-2.78 Million AUD	7.17%
2016	-2.99 Million AUD	3.5%
2015	-3.1 Million AUD	-151.58%
2014	-1.23 Million AUD	45.38%
2013	-2.26 Million AUD	0.0%

Year	Operating Income	Operating Income Growth
2024 FY	-22.21 Million AUD	-17.61%
2024 Q2	-12.09 Million AUD	0.0%
2024 Q4	-10.23 Million AUD	0.0%
2023 Q4	-12.29 Million AUD	0.0%
2023 FY	-18.89 Million AUD	-736.7%
2023 Q2	-6.71 Million AUD	0.0%
2022 Q4	-1.69 Million AUD	0.0%
2022 FY	2.96 Million AUD	90.56%
2022 Q2	4.63 Million AUD	0.0%
2021 FY	1.55 Million AUD	132.24%
2021 Q4	-2.81 Million AUD	0.0%
2021 Q2	4.28 Million AUD	0.0%
2020 Q2	-3.51 Million AUD	0.0%
2020 FY	-4.83 Million AUD	-34.2%
2020 Q4	-1.44 Million AUD	0.0%
2019 Q4	-2.86 Million AUD	0.0%
2019 Q2	-1.74 Million AUD	0.0%
2019 FY	-3.59 Million AUD	-5.91%
2018 Q4	-1.69 Million AUD	0.0%
2018 Q2	-1.7 Million AUD	0.0%
2018 FY	-3.39 Million AUD	-22.1%
2017 Q2	-1.33 Million AUD	0.0%
2017 FY	-2.78 Million AUD	7.17%
2017 Q4	-1.44 Million AUD	0.0%
2016 Q2	-1.61 Million AUD	0.0%
2016 Q4	-1.38 Million AUD	0.0%
2016 FY	-2.99 Million AUD	3.5%
2015 Q2	-1.35 Million AUD	0.0%
2015 Q4	-1.22 Million AUD	-58.11%
2015 FY	-3.1 Million AUD	-151.58%
2015 Q3	-776.66 Thousand AUD	42.79%
2015 Q1	- AUD	0.0%
2014 FY	-1.23 Million AUD	45.38%
2014 Q2	- AUD	0.0%
2014 Q3	- AUD	0.0%
2014 Q4	- AUD	0.0%
2013 FY	-2.26 Million AUD	0.0%

Peer Operating Income Comparison of Genetic Signatures Limited

Name	Operating Income	Operating Income Difference
Australian Clinical Labs Limited	56.9 Million AUD	139.246%
BCAL Diagnostics Limited	-5.44 Million AUD	-309.992%
Genetic Technologies Limited	-6.53 Million AUD	-241.631%
Healius Limited	39.7 Million AUD	156.254%
Imagion Biosystems Limited	-15.81 Million AUD	-41.22%
Integral Diagnostics Limited	5.36 Million AUD	516.117%
INOVIQ Ltd	-9.51 Million AUD	-134.824%
Microba Life Sciences Limited	-26.84 Million AUD	16.801%
Monash IVF Group Limited	-5.34 Million AUD	-317.908%
Rhythm Biosciences Limited	-6.7 Million AUD	-232.969%
Sonic Healthcare Limited	816.45 Million AUD	102.735%